Nurocor is a Representative Vendor in latest Gartner® research

by Jan 11, 2023

Nurocor listed as a Representative Vendor in the Gartner® Innovation Insight: Digital Protocol for Clinical Trials report

Nurocor, the leading vendor in digitalized clinical development solutions, is identified as a 2022 Gartner® Hype Cycle™ for Life Science Clinical Development, sample vendor in two categories: Structured Content and Component Authoring, and Clinical Data Analytics Platforms.

Gartner® Innovation Insight: Digital Protocol for Clinical Trials report

According to Gartner, “The digital protocol is an evolving concept in which a clinical trial protocol is developed as digital content and is then reproducible as an electronic document. Life science CIOs should consider the digital protocol as part of the digital transformation of their trial architectures and solutions.”

Using our tech expertise and industry experience, Nurocor turns digital transformation into digital acceleration. Our goal is to create lasting value throughout the journey to a digitalized clinical development process. Nurocor Clinical Platform delivers a modular suite of digital protocol applicationsthat connect people, process, and technologies to break the document paradigm. In digital form protocol content is actionable and reusable and our platform approach can conservatively reduce the cost and execution time of a typical phase III clinical trial by $8 million and 8 months. Driving digitalization through our gated Lean Protocol™ workflow enables clinical development teams to innovate drug development and bring new therapies to patients rapidly.  

In the words of a Nurocor customer “Unlike other software vendors Nurocor is not just an order taker, it approaches domain problems from a first principles perspective and as a result produces innovative solutions”.

GARTNER Disclaimer:

GARTNER is a registered trademark and service mark of Gartner, Inc. and/or its affiliates in the U.S. and internationally and is used here in with permission. All rights reserved.

Gartner does not endorse any vendor, product or service depicted in its research publications, and does not advise technology users to select only those vendors with the highest ratings or other designation. Gartner research publications consist of the opinions of Gartner research organization and should not be construed as statements of fact. Gartner disclaims all warranties, express or implied, with respect to this research, including any warranties of merchantability or fitness for a particular purpose.